Role of dopaminergic neuronal system in dizocilpine-induced acetylcholine release in the rat brain M. HasegawaK. YamadaT. Nabeshima OriginalPaper Pages: 651 - 660
Regional differences of the effect of σ receptor ligands on the acetylcholine release in the rat brain T. KobayashiK. MatsunoS. Mita OriginalPaper Pages: 661 - 669
Effects of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain T. AbekawaT. OhmoriT. Koyama OriginalPaper Pages: 671 - 680
Monoamine oxidase gene transcription in human cell lines: Treatment with psychoactive drugs and ethanol J. EkblomQ. -S. ZhuJ. C. Shih OriginalPaper Pages: 681 - 692
Anti-serotonergic effects of urethane and chloral hydrate may not be mediated by a blockade of 5-HT2 receptors H. C. DringenbergG. B. BakerC. H. Vanderwolf Short Communication Pages: 693 - 698
Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study H. PrzuntekD. WelzelK. Überla OriginalPaper Pages: 699 - 715
Sustained-release of levodopa: single dose study of a new formulation M. GerlachW. KuhnH. Przuntek OriginalPaper Pages: 717 - 727
COMT inhibition by entacapone does not affect growth hormone or prolactin secretion in healthy volunteers T. KeränenA. GordinT. Wikberg OriginalPaper Pages: 729 - 736
Motor actions of eliprodil in the normal and monoamine-depleted mouse: A role in the treatment of Parkinson's disease? S. BrooksS. KaurM. S. Starr OriginalPaper Pages: 737 - 748
Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine L. NaylorB. DeanD. Copolov OriginalPaper Pages: 749 - 757